Strong Market Leadership EMS has maintained its position as the leading pharmaceutical company in Brazil for 19 consecutive years, with a dominant share in prescription medicines, generics, OTC, and hospital segments, indicating a robust and expanding customer base within the healthcare sector.

Global Innovation Presence The company's investments in advanced research facilities in Latin America, Italy, and the US, along with recent FDA-approved innovations, point to significant opportunities for partners involved in cutting-edge medical device and biotech collaborations worldwide.

Expanding Export Footprint With exports to over 40 countries, EMS's international reach suggests a growing demand for its products, especially in markets seeking high-quality, locally manufactured pharmaceuticals, opening avenues for sales of raw materials, packaging, and distribution services.

Strategic R&D Focus EMS’s focus on high-complexity generics and biologics, supported by its modern research centers, presents opportunities for suppliers and technology providers specializing in biotech, formulation, and manufacturing process innovations.

Social Responsibility & Reputation The company's partnerships with WHO and commitments to social causes enhance its reputation, creating potential to collaborate on healthcare projects, social initiatives, or corporate social responsibility programs that align with sustainability and social impact values.